CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- POS AM Other Post-effective Amendment for Registration Statement
- RW Other RW
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Executive or director change · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Other events
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
Page 44 of 80 · 1,585 filings